胺碘酮治疗老年恶性室性心律失常的有效性及安全性分析  

The Efficacy and Safety of Amiodarone in the Treatment of Senile Malignant Ventricular Arrhythmia

作　　者：徐丹 XU Dan(The First People's Hospital of Jinzhou District,Dalian 116100,China)

机构地区：[1]大连市金州区第一人民医院,辽宁大连116100

出　　处：《中国医药指南》2021年第35期82-83,共2页Guide of China Medicine

摘　　要：目的探究胺碘酮治疗老年恶性室性心律失常的临床有效性及安全性。方法选取我院2018年5月至2019年6月收治的113例老年恶性室性心律失常患者为研究对象,按照住院病床号的奇偶将所有患者分为对照组与观察组。对照组根据病情应用对症治疗方案,研究组在对照组的治疗基础之上加用胺碘酮。记录并分析两组的临床治疗效果及不良反应的发生情况。结果经对比,观察组的临床治疗有效率高于对照组,P<0.05;观察组的不良反应发生率低于对照组,P<0.05。结论老年恶性室性心律失常患者应用胺碘酮后,临床治疗有效性得到了明显的提升,同时也具有理想的药物应用安全性。因此在实际治疗工作中可以为老年恶性室性心律失常患者使用胺碘酮治疗。Objective To explore the clinical efficacy and safety of amiodarone in the treatment of elderly patients with malignant ventricular arrhythmia.Methods One hundred and thirteen elderly patients with malignant ventricular arrhythmia in our hospital from May 2018 to June 2019 were selected as the research objects,and all patients were divided into the control group and the observation group according to the odd and even number of hospital beds.The control group was treated with symptomatic treatment according to the condition,and the study group was treated with amiodarone based on the treatment of the control group.The clinical effects and adverse reactions of the two groups were recorded and analyzed.Results After comparison,the clinical effective rate of the observation group was higher than that of the control group,P<0.05;the incidence of adverse reactions of the observation group was lower than that of the control group,P<0.05.Conclusion Amiodarone for elderly patients with malignant ventricular arrhythmia,clinical treatment effectiveness has been significantly improved,but also has ideal drug safety,so it can be used in the actual treatment of elderly patients with malignant ventricular arrhythmia.

关 键 词：胺碘酮 心律失常 临床疗效 

分 类 号：R541.7[医药卫生—心血管疾病]